Lista de obras - Golo Ahlenstiel - Dominio Público Uruguay

A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses

artículo científico publicado en 2014

Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon

artículo científico publicado en 2014

Adiponectin confers protection from acute colitis and restricts a B cell immune response.

artículo científico publicado en 2017

Artefactual "in-vitro coagulopathy" in a patient with non-Hodgkin lymphoma and lower gastrointestinal bleeding

artículo científico publicado en 2014

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

artículo científico publicado en 2004

CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?

artículo científico publicado en 2004

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection.

artículo científico publicado en 2013

CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury

scientific article published on 10 July 2019

Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori

artículo científico publicado en 2017

Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.

artículo científico publicado en 2014

Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles.

artículo científico publicado en 2008

Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer

artículo científico publicado en 2006

Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

artículo científico publicado en 2008

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

artículo científico publicado en 2011

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

artículo científico publicado en 2011

Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.

artículo científico publicado en 2013

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.

artículo científico publicado en 2003

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.

artículo científico publicado en 2009

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.

artículo científico publicado en 2009

Endoscopic resection of large duodenal and papillary lateral spreading lesions is clinically and economically advantageous compared with surgery.

artículo científico publicado en 2017

Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients

artículo científico publicado en 2020

FibroGENE: A gene-based model for staging liver fibrosis

artículo científico publicado en 2015

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

artículo científico publicado en 2002

Gastric Cancer Screening in Common Variable Immunodeficiency

artículo científico publicado en 2018

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

scientific article published on 30 March 2020

HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells

artículo científico publicado en 2005

Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent.

artículo científico publicado en 2014

Hepatitis C virus and the threshold of natural killer cell inhibition.

artículo científico publicado en 2005

IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.

artículo científico publicado en 2013

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

artículo científico publicado en 2014

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection

artículo científico publicado en 2016

IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.

artículo científico publicado en 2010

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study

artículo científico publicado en 2011

Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis

artículo científico publicado en 2008

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

artículo científico publicado en 2011

Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes).

artículo científico publicado en 2008

Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection

scientific article published on 06 April 2020

Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection

artículo científico publicado en 2004

Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection

artículo científico publicado en 2013

Interferon Lambda and Liver Fibrosis

scientific article published on 22 April 2019

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

artículo científico publicado en 2015

KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B

artículo científico publicado en 2019

Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection.

artículo científico publicado en 2009

Macrophage Coordination of the Interferon Lambda Immune Response

scientific article published on 19 November 2019

Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses

artículo científico publicado en 2022

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

scholarly article

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

artículo científico publicado en 2009

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

artículo científico publicado en 2009

Non-coding RNA and immune-checkpoint inhibitors: friends or foes?

scientific article published on 07 May 2020

Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

artículo científico publicado en 2013

Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection.

artículo científico publicado en 2014

S-Adenosyl Methionine Improves Early Viral Responses and Interferon-Stimulated Gene Induction in Hepatitis C Nonresponders ⬇️

artículo científico publicado el 17 de septiembre de 2010

Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation: a case report

artículo científico publicado en 2015

Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.

artículo científico publicado en 2006

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

artículo científico publicado en 2005

The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients

artículo científico publicado en 2007

The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression

artículo científico publicado en 2019

The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus

scientific article published on 17 June 2019

The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

artículo científico publicado en 2020

The antiviral role of zinc and metallothioneins in hepatitis C infection.

artículo científico publicado en 2017

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.

artículo científico publicado en 2010

The natural killer cell response to HCV infection.

artículo científico publicado en 2013

The role of obesity in inflammatory bowel disease

scientific article published on 22 October 2018

The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection.

artículo científico publicado en 2006

The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.

artículo científico publicado en 2008

Validated computed cleansing score for video capsule endoscopy

artículo científico publicado en 2015

Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?

artículo científico

Zinc is a potent and specific inhibitor of IFN-λ3 signalling.

artículo científico publicado en 2017

[Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?]

artículo científico publicado en 2002

Lista de obras de Golo Ahlenstiel

A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses

Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon

Adiponectin confers protection from acute colitis and restricts a B cell immune response.

Artefactual "in-vitro coagulopathy" in a patient with non-Hodgkin lymphoma and lower gastrointestinal bleeding

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection.

CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury

Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori

Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.

Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles.

Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer

Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.

Endoscopic resection of large duodenal and papillary lateral spreading lesions is clinically and economically advantageous compared with surgery.

Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients

FibroGENE: A gene-based model for staging liver fibrosis

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

Gastric Cancer Screening in Common Variable Immunodeficiency

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells

Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent.

Hepatitis C virus and the threshold of natural killer cell inhibition.

IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection

IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study

Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes).

Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection

Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection

Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection

Interferon Lambda and Liver Fibrosis

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B

Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection.

Macrophage Coordination of the Interferon Lambda Immune Response

Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

Non-coding RNA and immune-checkpoint inhibitors: friends or foes?

Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection.

S-Adenosyl Methionine Improves Early Viral Responses and Interferon-Stimulated Gene Induction in Hepatitis C Nonresponders ⬇️

Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation: a case report

Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients

The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression

The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus

The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

The antiviral role of zinc and metallothioneins in hepatitis C infection.

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.

The natural killer cell response to HCV infection.

The role of obesity in inflammatory bowel disease

The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection.

The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.

Validated computed cleansing score for video capsule endoscopy

Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?

Zinc is a potent and specific inhibitor of IFN-λ3 signalling.

[Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?]